Bone cement is mainly known as Plexiglas i.e., polymethylmethacrylate (PMMA), and is broadly used for implant fixation in several orthopaedic, dental, and trauma surgeries. Bone cement is mostly used for attaching artificial joints. It performs a role of an elastic zone by plugging the vacant space between the bone and the artificial body part.
DePuy Synthase (The Orthopaedics Company of Johnson & Johnson) and Zimmer Biomet – Notable Market Players in Bone Cement Market
Market leaders operating in the market have undertaken various organic growth strategies in the bone cement market. The bone cement market majorly consists of the players are DePuy Synthase (The Orthopaedics Company of Johnson & Johnson); Zimmer Biomet; Smith & Nephew, DJO Global, Inc.; Arthrex, Inc.; Tecres S.p.A.; Heraeus Holding GmbH; Cardinal Health Inc; Teknimed; and Stryker Corporation. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaboration.
Below is the list of the growth strategies done by the players operating in the Bone Cement Market:
| Company | Month & Year | Category | Description |
| Zimmer Biomet | Jan’21 | Company News | Zimmer Biomet won a U.S. International Trade Commission case in which it was accused of stealing Heraeus trade secrets for bone cement, the compound used to fill the gap between an artificial joint and a bone. The commission rejected Heraeus Holding request to block the imports of Refobacin bone cements made in France thar competes with Heraeus ‘s PALACOS product |
| Zimmer Biomet | Aug’19 | Company News | Zimmer Biomet filed a complaint with the U.S. International Trade Commission seeking to bar the Heraeus Holding from importing its bone cement products. Zimmer argued that prohibiting importation of Heraeus’ bone cement products would not harm the public health, safety or welfare of U.S. citizens. |
Source: The Insight Partners Analysis, Website, Press Releases and Others
